UNIVEST FINANCIAL Corp lessened its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 2.0% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 31,713 shares of the healthcare conglomerate's stock after selling 649 shares during the quarter. UnitedHealth Group makes up about 1.0% of UNIVEST FINANCIAL Corp's portfolio, making the stock its 22nd biggest position. UNIVEST FINANCIAL Corp's holdings in UnitedHealth Group were worth $16,043,000 as of its most recent filing with the Securities and Exchange Commission.
Other hedge funds have also recently made changes to their positions in the company. Raymond James Financial Inc. bought a new stake in shares of UnitedHealth Group in the 4th quarter valued at about $1,914,740,000. Amundi grew its holdings in UnitedHealth Group by 97.2% in the fourth quarter. Amundi now owns 6,069,100 shares of the healthcare conglomerate's stock worth $3,183,132,000 after purchasing an additional 2,991,470 shares during the last quarter. Proficio Capital Partners LLC lifted its holdings in shares of UnitedHealth Group by 76,830.4% during the 4th quarter. Proficio Capital Partners LLC now owns 1,888,641 shares of the healthcare conglomerate's stock valued at $955,388,000 after purchasing an additional 1,886,186 shares during the last quarter. Caisse DE Depot ET Placement DU Quebec increased its position in UnitedHealth Group by 129.7% during the 3rd quarter. Caisse DE Depot ET Placement DU Quebec now owns 1,029,540 shares of the healthcare conglomerate's stock valued at $601,951,000 after buying an additional 581,324 shares in the last quarter. Finally, State Street Corp boosted its holdings in UnitedHealth Group by 1.3% in the third quarter. State Street Corp now owns 45,540,102 shares of the healthcare conglomerate's stock worth $26,626,387,000 after acquiring an additional 563,554 shares in the last quarter. 87.86% of the stock is currently owned by hedge funds and other institutional investors.
Analysts Set New Price Targets
A number of research firms recently commented on UNH. Piper Sandler lowered their target price on shares of UnitedHealth Group from $605.00 to $600.00 and set an "overweight" rating for the company in a research note on Thursday, January 2nd. KeyCorp restated an "overweight" rating and issued a $650.00 target price on shares of UnitedHealth Group in a research note on Friday, January 17th. Truist Financial cut their price objective on UnitedHealth Group from $625.00 to $610.00 and set a "buy" rating on the stock in a report on Monday, January 6th. Barclays reduced their price target on shares of UnitedHealth Group from $655.00 to $642.00 and set an "overweight" rating for the company in a research report on Friday, January 17th. Finally, Stephens lifted their price objective on UnitedHealth Group from $605.00 to $675.00 and gave the company an "overweight" rating in a research note on Thursday, December 5th. Twenty analysts have rated the stock with a buy rating and two have given a strong buy rating to the company's stock. According to data from MarketBeat.com, the company currently has a consensus rating of "Buy" and an average price target of $629.32.
Check Out Our Latest Report on UnitedHealth Group
UnitedHealth Group Price Performance
UNH traded down $0.25 on Friday, reaching $515.47. 2,378,211 shares of the company's stock were exchanged, compared to its average volume of 4,268,981. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91. The stock's fifty day moving average price is $508.81 and its 200-day moving average price is $544.24. UnitedHealth Group Incorporated has a twelve month low of $436.38 and a twelve month high of $630.73. The stock has a market cap of $471.51 billion, a PE ratio of 33.26, a P/E/G ratio of 1.37 and a beta of 0.62.
UnitedHealth Group (NYSE:UNH - Get Free Report) last issued its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share (EPS) for the quarter, beating the consensus estimate of $6.74 by $0.07. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The firm had revenue of $100.81 billion for the quarter, compared to analyst estimates of $101.60 billion. During the same period in the previous year, the firm earned $5.83 EPS. UnitedHealth Group's revenue was up 6.8% on a year-over-year basis. Sell-side analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.
UnitedHealth Group Announces Dividend
The company also recently disclosed a quarterly dividend, which was paid on Tuesday, March 18th. Stockholders of record on Monday, March 10th were paid a $2.10 dividend. The ex-dividend date was Monday, March 10th. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.63%. UnitedHealth Group's payout ratio is presently 54.19%.
Insider Buying and Selling
In other news, Director Timothy Patrick Flynn acquired 1,000 shares of the company's stock in a transaction on Friday, January 17th. The shares were bought at an average cost of $511.57 per share, with a total value of $511,570.00. Following the transaction, the director now owns 4,500 shares in the company, valued at approximately $2,302,065. This trade represents a 28.57 % increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. 0.33% of the stock is owned by corporate insiders.
UnitedHealth Group Profile
(
Free Report)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Recommended Stories

Before you consider UnitedHealth Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.
While UnitedHealth Group currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Options trading isn’t just for the Wall Street elite; it’s an accessible strategy for anyone armed with the proper knowledge. Think of options as a strategic toolkit, with each tool designed for a specific financial task. Get this report to learn how options trading can help you use the market’s volatility to your advantage.
Get This Free Report